Title 21 Job Opportunities
The 21st Century Cures Act was enacted on December 13, 2016 and Section 3072 of the Act grants the Commissioner of Food and Drugs the authority to appoint and set the annual rate of pay for outstanding and qualified candidates to scientific, technical, or professional positions that support the development, review, and regulation of medical products. The FY23 Food and Drug Omnibus Reform Act expanded this authority further amending Title 21 to include cross-cutting operational positions and individuals that support the development review and regulation of food and cosmetics in addition medical products. (codified into Title 21 of the United States Code (21 US Code 379d-3a).
The positions listed below are being filled under Title 21. The candidate selected for these positions will serve under a career or career-conditional appointment and be paid under the provisions of the authority. Additional information on 21st Century Cures Act can be found here
Title 21 Open Vacancies
Regulatory Specialist
Center for Drug Evaluation and Research (CDER)
Closing Date: June 28, 2024
Translation
Deputy Office Director, Office of Facilities Engineering and Mission Support Services
Office of the Commissioner (OC)
Closing Date: June 14, 2024
Deputy Office Director
Center for Drug Evaluation and Research (CDER)
Closing Date: June 14, 2024
Regulatory Health Project Manager
Center for Biologics Evaluation and Research (CBER)
Closing date: July 11, 2024
Epidemiologist
The Center for Drug Evaluation and Research (CDER)
Closing Date: June 27, 2024
Clinical Analyst
The Center for Drug Evaluation and Research (CDER)
Closing Date: June 14, 2024
Mathematical Statistician
Center for Biologics Evaluation and Research (CBER)
Closing date: June 12, 2024
Office Director (Supervisory Business Informaticist)
The Center for Drug Evaluation and Research (CDER)
Closing Date: June 27, 2024
Senior Public Health Advisor
Office of the Commissioner (OC)
Closing date: June 21, 2024
Division Director
Center for Biologics Evaluation and Research (CBER)
Closing date: June 22, 2024
Senior Investigator III (Foreign)
Office of Regulatory Affairs (ORA)
Closing Date: June 17, 2024
Senior Investigator II
Office of Regulatory Affairs (ORA)
Closing Date: June 17, 2024
Deputy Office Director
The Center for Drug Evaluation and Research (CDER)
Closing Date: June 13, 2024
Investigator II
Office of Regulatory Affairs (ORA)
Closing Date: July 22, 2024
Investigator II / Senior Investigator I
Office of Regulatory Affairs (ORA)
Closing date: July 15, 2024
Investigator II / Senior Investigator I
Office of Regulatory Affairs (ORA)
Closing date: July 15, 2024
Physician
Center for Biologics Evaluation and Research (CBER)
Closing date: Open continuously; applications will be reviewed periodically
Investigator II/Senior Investigator I
Office of Regulatory Affairs (ORA)
Closing date: July 22, 2024
Investigator II
Office of Regulatory Affairs (ORA)
Closing date: July 10, 2024
Physician, Office of Therapeutic Products (OTP)
Center for Biologics Evaluation and Research (CBER)
Open continuously; applications will be reviewed periodically
Physician
Center for Biologics Evaluation and Research (CBER)
Open continuously; applications will be reviewed periodically.